The low expression of CXCR4 in bone metastases reported by Eaton et al. [41] suggests that this marker (with its ligand SDF-1) could be important for cancer cell homing to bone and stem cell trafficking [57, 58], but not for distant tumour growth [41]. Here, CXCL12 is linked to cancer.